-
Infection and Drug Resistance
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Treatment of drug-resistant tuberculosis
Evidence to Practice
(10260) Views (898) Full article downloads
Authors: Pinto LM, Menzies D
Published Date July 2011
Volume 2011:4 Pages 129 - 135
DOI: http://dx.doi.org/10.2147/IDR.S10332
Lancelot Pinto1,2, Dick Menzies1,21Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, Montreal, QC, Canada; 2Department of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada
Clinical question: What is the best approach to the treatment of drug-resistant tuberculosis (TB)?
Results: Evidence-based treatment of drug-susceptible TB is the best means of preventing the development of drug-resistant disease. Suspecting the possibility of drug-resistant TB, and prompt detection of all forms of drug-resistant TB, not only multidrug-resistant and extensively drug-resistant TB, should be part of the algorithm for diagnosis and management of all patients with active TB.
Implementation: Treatment of all forms of drug-resistant TB must be tailored to the specific form of resistance with appropriate and effective drug regimens.
Keywords: drug-resistant tuberculosis, MDR-TB, treatment
Readers of this article also read:
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
The use of anti-tuberculosis therapy for latent TB infection
Lyme disease: the next decade
Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?
Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
- Treatment of drug-resistant tuberculosis
- Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome
- High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India




